US Congress Senate Bill 3250 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on February 4 2020 - 25% progression, died in committee
Action: 2020-02-04 - Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Pending: Senate Homeland Security And Governmental Affairs Committee
Text: Latest bill text (Introduced) [PDF]

Establishes new requirements related to the detection of illicit narcotics at ports of entry. Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition. Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.

DHS Opioid Detection Resilience Act of 2020

Sen. John Cornyn [R-TX]	Sen. Jacky Rosen [D-NV]	Sen. Bill Cassidy [R-LA]	Sen. Margaret Hassan [D-NH]
Sen. John Kennedy [R-LA]

Date	Chamber	Action
2020-02-04	Senate	Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

HB4761 (Related) 2020-12-23 - Became Public Law No: 116-254. (TXT | PDF)

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/3250/all-info
Text	https://www.congress.gov/116/bills/s3250/BILLS-116s3250is.pdf